Drug intelligence / Profile preview

Entty

Development stage: Unknown
Lead developer: Burke Therapeutics
Administration: Topical

Overview

**Entty** is a prescription, water-based topical spray emulsion marketed by Burke Therapeutics as an emollient skin-care product. It is used to manage and relieve burning and itching associated with dermatoses, including **atopic dermatitis** and **allergic contact dermatitis**. The formulation contains sodium hyaluronate and African palm oil and is intended to moisturize skin and support a moist skin environment; no specific molecular target or receptor-mediated mechanism has been publicly established.

Brand names: Entty
Other names: Entty Spray Emulsion

Beyond the preview

Go deeper on Entty.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Entty.

Explore the full profile